Abridge logo
Healthcare Medical Scribes · Audio Transcription

Abridge

Abridge is an enterprise healthcare AI platform that listens to the clinical conversation and turns it into draft notes, ICD-10 and HCC codes, nursing flowsheets and patient summaries inside the existing EHR, for 300+ health systems.

Active Enterprise No public API 18+ Verified by Guidaio
Overview

What is Abridge?

Abridge is an enterprise healthcare AI platform built by Abridge AI, Inc., headquartered in Pittsburgh, Pennsylvania. It listens to the clinical conversation and turns it into the documentation, codes and summaries that would otherwise be typed after hours. In 2026 the company describes itself as one intelligence layer connecting health systems, payers, and life sciences organizations, a step beyond the ambient scribe it started as.

The platform is sold as three product experiences. Abridge for Clinicians covers the visit end to end: it prepares the clinician beforehand from prior records, captures the encounter live alongside decision support, then returns a finished note, orders, codes and a patient summary. Abridge for Revenue Cycle works the coding side, with inpatient CDI written into the note rather than queried afterwards, real-time ICD-10 and HCC capture, automatic E&M leveling, and Care Signals, a risk adjustment capability co-developed with Kaiser Permanente that tracks MEAT criteria live. Abridge for Nursing drafts flowsheets, with Linked Sources tracing each entry back to what was said. Clinical Decision Support runs across all of it, answering questions from licensed sources including UpToDate, the NEJM, JAMA, the American Heart Association and the American Diabetes Association, with AMA PRA Category 1 CME credits available through MedicusCME.

Nothing runs as a separate tool. Abridge deploys inside the existing EHR — Epic, where it ships as Abridge Inside, plus Oracle Health, athenahealth and Cerner — so the clinician keeps the workflow they already have. Capture is validated in more than 28 languages, across specialties and care settings.

Scale is the strongest argument here: more than 300 health systems, over 100 million conversations a year, and named customers including Kaiser Permanente, Johns Hopkins Medicine, Duke Health, Yale New Haven Health and UPMC. Abridge was named Best in KLAS for ambient AI in 2025 and 2026, and is co-developing a clinical conversation foundation model with NVIDIA.

Two limits are stated by the company itself: every output is a draft, with the clinician always in the loop to review and sign, and Abridge does not practice medicine or provide medical advice. Pricing is enterprise-only and never published.

What it does

  • Capture the clinical conversation in real time and turn it into a structured draft note
  • Prepare the clinician before the visit with history, prior documents and care gaps
  • Answer clinical questions with cited decision support contextualized to the patient
  • Generate ICD-10 and HCC codes, visit diagnoses and the E&M level
  • Draft nursing flowsheets that link back to the source conversation
  • Adjust the generated output in natural language before it reaches the chart
  • Push everything into the EHR for clinician review and signature
Audience

When to use Abridge / When not to

A quick filter to help you decide if Abridge is the right fit.

When to use Abridge

  • Large health systems and multi-specialty groups already running Epic, Oracle Health, athenahealth or Cerner
  • Ambulatory and inpatient physicians across specialties who want the note drafted from the visit itself, as at Inova (40+ specialties) or Akron Children's (22 pediatric specialties)
  • Coding, CDI and compliance teams that need documentation traceable back to the recorded conversation at the moment of signature
  • Federal healthcare and VA organizations, addressed by the Abridge for Public Sector offering
  • Bedside nursing teams looking to cut flowsheet charting time during a shift

When not to use Abridge

  • Solo practitioners and small independent practices hoping to buy off the shelf: there is no public price and no self-service checkout, only a sales form
  • Anyone working outside healthcare, or on anything that does not start with a clinical conversation
  • European organizations that need a documented GDPR framework: the privacy policy is entirely US-based, hosting is in the United States and no Article 27 representative is named
  • Patients or clinicians expecting a diagnosis or medical advice: the terms state that Abridge does not engage in the practice of medicine, and use in a medical emergency is excluded
  • Anyone under 18, who is below the minimum age set by the terms
Get started

How to use Abridge

A typical end-to-end flow, from setup to results.

  1. Start from the contact form on the Abridge website: there is no public sign-up page
  2. Complete the five steps it asks for: work email and name, organization, EHR in use, your role and the size of your physician group
  3. Discuss scope and terms with the Abridge team, since the platform is licensed to the organization under an enterprise agreement with a HIPAA Business Associate Agreement incorporated into the clinician terms
  4. Have your IT team enable the integration inside the EHR you already run (Epic, Oracle Health, athenahealth or Cerner) rather than adding a separate application
  5. Set up SSO and the governance controls your institution requires
  6. Sign in at the Abridge notes portal, or open Abridge from within the EHR once your account is provisioned
  7. Before the visit, read the preparation Abridge has assembled: history, prior documents and care gaps for that patient
  8. During the encounter, simply speak normally while capture runs in the background, and query decision support in natural language if you need it
  9. After the encounter, review the draft note, codes, orders, flowsheets and patient summary, adjusting them in natural language where needed
  10. Sign the documentation yourself: nothing reaches the chart without clinician review
Quick read

Pros & Cons

Pros

  • Adoption that can be checked: 300+ health systems, including Kaiser Permanente, Johns Hopkins Medicine, Duke Health and Yale New Haven Health
  • Covers the whole chain rather than the note alone — preparation, capture, decision support, coding, nursing flowsheets and patient summary
  • Deploys inside the dominant EHRs instead of running as a parallel tool, with no new workflow to learn
  • Traceability is built in: each insight links back to its source and each code back to the conversation
  • Enterprise security baseline: SSO, 256-bit encryption, US hosting and a HIPAA Business Associate Agreement
  • The clinician stays in the loop by design: outputs are drafts and nothing is signed automatically
  • Strong external recognition and customer-published outcomes: Best in KLAS 2025 and 2026, TIME Best Inventions and Fast Company listings

Cons

  • No public pricing whatsoever: no pricing page, no rate card, no way to size a budget without talking to sales
  • No free trial and no free plan announced anywhere on the site
  • Enterprise-only sales, out of reach for a solo practice or a small independent clinic
  • An entirely US legal and technical framework: no GDPR mention, no Article 27 representative, hosting in the United States only
  • Transparency gaps on data: no subprocessor list is published, no opt-out from model training is documented, and de-identified derivatives of content belong to Abridge under the patient terms
  • No public API documentation despite the clinician terms referring to an API, and no store link for the mobile apps the terms and privacy policy describe
  • Outcome figures come from customer institutions with no methodology published on the site, and the terms impose binding arbitration with a class action waiver
Pricing

Pricing & Plans

Abridge publishes no price. There is no pricing page and no rate card on the website, and neither a free plan nor a free trial is announced: the platform is sold as an enterprise contract negotiated with each healthcare organization, and the only route to a quotation is the contact form. The clinician terms state that an Abridge account and the platform may be provided free of cost to a clinician through a third party, such as their health system or a health insurance company, while Abridge reserves the right to charge for future products. The privacy policy also refers to a self-serve route that collects payment card details for billing, so a paid path exists — but no amount, currency or billing unit is disclosed anywhere. An Impact Calculator is offered on the site, but it estimates economic impact, not price. Users remain responsible for their own access costs, such as internet connectivity.

Plan 1
  • Abridge for Clinicians — ambient documentation for ambulatory and inpatient care (no published price)
Plan 3
  • Abridge for Nursing — draft flowsheets for bedside nursing teams (no published price)
Plan 4
  • Clinical Decision Support — cited
  • contextual answers layered across the platform (no published price)
Plan 5
  • Abridge for Public Sector — federal healthcare and VA deployments (no published price)
Plan 6
  • Self-serve onboarding — referred to in the terms and privacy policy
  • with no dedicated page and no published price
Special offers — No promotional offer, discount code or dedicated student, non-profit or unemployed rate is published anywhere on the site · Free downloadable content in exchange for a form: the Best in KLAS 2025 and 2026 reports, the Scale & Impact Report, the KLAS nursing report and several whitepapers · The Impact Calculator is freely accessible on the website · Under the clinician terms, access can be free for the clinician when a third party, such as their health system or a health insurance company, pays for it
Prices and plans listed above may evolve. Always check the official pricing page before subscribing.
Trust & Privacy

Data, GDPR & hosting

A consolidated view of how Abridge handles your data.

GDPR overview

There is no mention of the GDPR anywhere on the Abridge website. The framework is entirely American: rights are described under US state laws such as California's CCPA/CPRA and Colorado's — the right to know, access, correct and delete, to opt out of sale or sharing, to object to profiling and to limit the use of sensitive data. The Global Privacy Control signal is honored. Abridge says it does not sell data for money, but does “share” identifiers for behavioral advertising in the CCPA sense. The company is US-based and data may be processed in the countries where its service providers sit. No Article 27 EU representative and no data protection officer is named. For health information, rights are exercised with the healthcare provider, not with Abridge, which acts as a HIPAA Business Associate under a BAA. The policy took effect on 27 August 2026.

Who owns the data?

Ownership is split. Under the patient terms, Your Content — the recordings and account information you provide — remains yours, but Abridge takes a worldwide, non-exclusive, royalty-free license over it, including the right to create derivative works. Those derivatives are the catch: de-identified or aggregated data generated by machine learning is excluded from Content and owned by Abridge, which may use it for any lawful business purpose. The clinician terms keep the Abridge Technology and Abridge Content with Abridge, leave User Content with the user but grant Abridge a perpetual, irrevocable, sublicensable license, and assign any Improvements arising from use to Abridge. Protected health information is a separate regime: Abridge processes it as a Business Associate on behalf of the healthcare organization, under the BAA rather than the privacy policy.

Reuse rights

Your own content stays reusable without asking anyone: recordings and account information remain yours under the patient terms, and nothing requires Abridge's permission to use them. What you do not control is the parallel track. Abridge holds a broad license over that content and owns every derivative it produces from it — de-identified or aggregated data generated by machine learning — which it may exploit for any lawful business purpose, typically to improve the service, with no accounting owed to you. Website and account data is used to run and improve the service, for support, security, marketing, research and development and legal compliance, and identifiers are shared with advertising partners, a “sharing” in the CCPA sense; FullStory session replay is named as a third-party technology, with an opt-out. On the clinical decision support side, Abridge states that queries run entirely inside Abridge's architecture. PHI never leaves it and is never used for training. The foundation model built with NVIDIA is described as trained on de-identified data. No option to exclude customer data from model training is documented anywhere. An optional biometric voiceprint in the mobile apps is consent-based and used only to improve voice recognition.

Data retention & training

Retention summary
Personal data collected through the website and accounts is kept for as long as Abridge has a legitimate business need for it, judged on where the data came from, why it was collected, how sensitive it is and what legal, tax, accounting or contractual obligations apply. Once that need ends, the data is deleted or anonymized; where deletion is impossible, for example in backup archives, it is stored securely and isolated from any further processing until deletion becomes possible. An optional biometric voiceprint is destroyed one year after the last use of the mobile app, on account deletion or on request, from production systems and backups alike. Customer Data, including protected health information, follows the agreement with the health system rather than the privacy policy, and no retention period is published for audio recordings or clinical notes. The policy took effect on 27 August 2026.
Trains on customer data
Unclear
DPA available
Yes
GDPR contact

Hosting summary

Abridge states that it stores all data in secure, U.S. based centers that meet strict standards, with 256-bit encryption in transit and at rest. Access is controlled through SSO, and each health system can configure its own governance controls. Beyond that country-level statement, no hosting provider, cloud region or data center location is named, and no European or other regional option is offered. The privacy policy adds a nuance worth reading: the company is based in the United States, its service providers may sit in other countries, and personal data may therefore be processed in those countries. Customer Data, including protected health information, is handled as a Business Associate on behalf of the healthcare organization and is governed by the agreement with that customer rather than by the published policy. The website itself is served behind Cloudflare, which is a front-end delivery arrangement and says nothing about where clinical data is stored.

Hosting countries
🇺🇸 United States
Watch-outs

Things to keep in mind

Risks and trade-offs to weigh before adopting Abridge.

  • Under the patient terms, de-identified or aggregated derivatives of your content belong to Abridge and may be used for any lawful business purpose, with no accounting owed to you
  • The clinician terms grant Abridge a perpetual, irrevocable and sublicensable license over User Content, and assign to Abridge any Improvements arising from use
  • Disputes go to binding AAA arbitration with a jury trial and class action waiver; opting out requires an email to legal@abridge.com within 30 days
  • Liability is capped at the greater of USD 1,000 or the amounts paid over the preceding twelve months, under Pennsylvania law with jurisdiction in Pittsburgh
  • The clinician alone is responsible for obtaining patient consent to recording, and US wiretapping rules vary from state to state
  • No subprocessor list and no opt-out from model training are published, and website identifiers are shared with advertising partners, a “sharing” in the CCPA sense
  • Every output is a draft that still has to be read: signing an AI-written note without checking it moves the error from the machine onto the clinician, and habitual over-reliance can quietly erode documentation and listening skills
Setup

Setup & Integrations

Technical difficulty

Low for the clinician, moderate for the organization. Nothing is self-installed: Abridge is deployed with the vendor inside the EHR the institution already runs, which the contact form asks about upfront along with the size of the group. The organizational prerequisites are the real work — an enterprise agreement, a Business Associate Agreement, SSO and governance controls. Once live, the clinician experience is deliberately unremarkable: speak normally during the encounter, then review and sign the drafts, with no new workflow to learn. Deployments of several thousand clinicians are documented, so scale is not the obstacle.

Deployment

Web appMobile app

Integrations

Epic Oracle Health Athenahealth Cerner Artisight Hellocare.ai UpToDate The New England Journal of Medicine JAMA
Company

Behind Abridge

Company name
Abridge AI, Inc.
Founded
INFORMATION_NOT_FOUND
Country of origin
🇺🇸 United States
Headquarters
500 Grant Street, Suite 2900, Pittsburgh, PA 15219
US office
500 Grant Street, Suite 2900, Pittsburgh, PA 15219
UBO
INFORMATION_NOT_FOUND
UBO country
INFORMATION_NOT_FOUND
Domain registrar country
🇺🇸 United States
Legal contact
Support contact

Fundraising

Series E of USD 300 million led by Andreessen Horowitz (a16z), announced by Abridge on its own blog on 23 June 2025 — the only first-party funding source found
Khosla Ventures named among the participants in that round by the specialist press
Valuation of USD 5.3 billion associated with the Series E, reported by the specialist press and not confirmed on the Abridge website
Series E extension of USD 316 million reported in April 2026 at the same USD 5.3 billion valuation, sourced only from the specialist press with no first-party announcement found
Earlier investors named by third parties: Union Square Ventures, Bessemer Venture Partners, Lightspeed Venture Partners, Redpoint Ventures, IVP, CVS Health Ventures and Kaiser Permanente Ventures
No investors page and no funding recap are published on the Abridge website

Social

Official links

Resources

All the official URLs gathered for verification and reference.

FAQ

Frequently asked questions

What does Abridge actually do?
It captures the clinical conversation and turns it into a draft note, ICD-10 and HCC codes, an E&M level, orders, nursing flowsheets and a patient summary, all returned into the EHR for the clinician to review and sign.
How much does Abridge cost?
No price is published. Abridge is sold as an enterprise contract negotiated organization by organization, and the only way to get a figure is the contact form on the website.
Is there a free trial?
Nothing of the sort is announced on the site. The clinician terms note only that access may be provided free of cost to a clinician when a third party, such as their health system or a health insurer, pays for it.
Which EHRs does Abridge work with?
Epic, where it ships as Abridge Inside and has moved from Haiku to Hyperdrive, plus Oracle Health, athenahealth and Cerner, the latter documented through a customer deployment at Rady Children's.
Is Abridge HIPAA compliant?
Abridge presents itself as HIPAA compliant and acts as a Business Associate for its healthcare customers, with a Business Associate Agreement incorporated by reference into the clinician terms. The text of that BAA is not published.
Is Abridge GDPR compliant?
The website makes no claim either way: the GDPR is never mentioned. The privacy framework is American, built on CCPA/CPRA and other state laws, data is hosted in the United States and no Article 27 EU representative is named.
Is my data used to train the models?
The answer depends on the scope. The decision support page states that PHI never leaves Abridge's architecture and is never used for training. The patient terms, however, make de-identified derivatives produced by machine learning the property of Abridge, and the foundation model built with NVIDIA is described as trained on de-identified data. No opt-out from training is documented.
Where is the data hosted?
In US-based data centers, with 256-bit encryption in transit and at rest. No hosting provider or cloud region is named, and the privacy policy adds that service providers may sit in other countries and process data there.
How many languages does Abridge support?
More than 28 validated languages are claimed in the June 2026 announcement, across specialties and care settings. No list of the individual languages is published.
Is there an API?
The clinician terms refer to an application programming interface, so one plausibly exists for customers, but no public API documentation is exposed on the website.
Conclusion

Should you pick Abridge?

Abridge is the reference point for ambient clinical AI, and the evidence is not just marketing: more than 300 health systems, over 100 million conversations a year, Best in KLAS for ambient AI two years running, and named deployments at Kaiser Permanente, Johns Hopkins Medicine, Duke Health and Yale New Haven Health. The product has also outgrown the scribe category it helped create. Coding and risk adjustment, inpatient CDI, nursing flowsheets and cited clinical decision support now sit on the same capture, all of it delivered inside Epic, Oracle Health, athenahealth or Cerner rather than beside them.

The trade-off is access. Nothing here is for an individual: no published price, no free plan, no trial, no self-service sign-up — an enterprise contract negotiated organization by organization, entered through a sales form. For a European buyer there is a second obstacle. The legal and technical framework is entirely American: HIPAA and a Business Associate Agreement, US data centers, privacy rights written against California and other state laws, and not a single mention of the GDPR or an Article 27 representative anywhere on the site.

Three points deserve a direct answer before signing. Model training: Abridge says PHI never leaves its architecture and is never used for training on the decision support side, yet the patient terms give it ownership of de-identified derivatives and the NVIDIA foundation model is trained on de-identified data, with no documented opt-out. Subprocessors: no list is published. Retention: no figure is given for audio recordings or clinical notes, which are governed by the customer agreement instead.

For a US health system already running a major EHR, Abridge is a serious, well-instrumented candidate whose clinician-in-the-loop design is genuinely reassuring. For anyone else, those questions come first.